Michael Gelband’s Clene CLNN Stock Holding History

Michael Gelband’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,234	Closed	-$1.34M	–	2402
2021 Q1	$1.34M	Buy	+5,234	New	+$1.15M	0.02%	757

Other funds holding CLNN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Michael Gelband's CLNN Position: Q2 2021 in Review

Michael Gelband sold out of Clene (CLNN) in Q2 2021, closing a stake of 5,234 shares — an estimated $1.34M sold.

Michael Gelband first reported a position in CLNN in Q1 2021 and held it in 1 quarter. The position peaked at $1.34M in Q1 2021. 35 funds tracked by Wall St. Rank hold CLNN as of Q2 2021.

Michael Gelband reported no remaining Clene position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 5,234 Clene shares in Q2 2021, an estimated $1.34M.
Michael Gelband first reported a position in Clene in Q1 2021 and held it in 1 quarter.
Michael Gelband's Clene position peaked at $1.34M in Q1 2021.
35 funds tracked by Wall St. Rank held Clene as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.